EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone

Biochemical Pharmacology

Volumn 86, Issue 6, 2013, Pages 734-747

  Dang, Yiping ^a   Li, Wei ^a   Tran, Victoria ^a   Khalil, Raouf A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Blood vessels; Myometrium; Placenta; Sex hormones

Indexed keywords

CD147 ANTIGEN; ESTROGEN; GELATIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; UPREGULATION; UTERUS; VASCULAR TISSUE; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84885184327     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.06.030     Document Type: Article

References (73)

1. OuzounianJG, Elkayam U. Physiologic changes during normal pregnancy and delivery. Cardiol Clin 2012; 30: 317-29.
2. Majed BH, Khalil RA. Molecular mechanisms regulating the vascular prosta-cyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev 2012; 64: 540-82.
3. Mandala M, Osol G. Physiological remodelling of the maternal uterine circulation during pregnancy. Basic Clin Pharmacol Toxicol 2012; 110: 12-8.
4. Valdes G, Corthorn J. Review: the angiogenic and vasodilatory utero-placental network. Placenta 2011; 32(Suppl. 2): S170-5.
5. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metal-loproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-39. (Pubitemid 36542523)
6. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 75: 346-59. (Pubitemid 350298459)
7. Moreira L, de Carvalho EC, Caldas-Bussiere MC. Differential immunohisto-chemical expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cow uteri with adenomyosis during follicular phase. Vet Res Commun 2011; 35: 261-9.
8. Kizaki K, Ushizawa K, Takahashi T, Yamada O, Todoroki J, Sato T, et al. Gelatinase (MMP-2 and -9) expression profiles during gestation in the bovine endometrium. Reprod Biol Endocrinol 2008; 6: 66.
9. Ulbrich SE, Meyer SU, Zitta K, Hiendleder S, Sinowatz F, Bauersachs S, et al. Bovine endometrial metallopeptidases MMP14 and MMP2 and the metallo-peptidase inhibitor TIMP2 participate in maternal preparation of pregnancy. Mol Cell Endocrinol 2011; 332: 48-57.
10. MishraB, KizakiK, KoshiK, UshizawaK, TakahashiT, HosoeM, et al. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle. Reprod Biol Endocrinol 2010; 8: 60.
11. ZhangX, Qi C, Lin J. Enhanced expressions of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding. Fertil Steril 2010; 93: 2362-7.
12. Yin Z, Sada AA, Reslan OM, Narula N, Khalil RA. Increased MMPs expression and decreased contraction in the rat myometrium during pregnancy and in response to prolonged stretch and sex hormones. Am J Physiol Endocrinol Metab 2012; 303: E55-70.
13. Merchant SJ, Davidge ST. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia. BJOG 2004; 111: 931-9. (Pubitemid 39223042)
14. Risberg A, Olsson K, Lyrenas S, Sjoquist M. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand 2009; 88: 639-46.
15. Gaspar R, Foldesi I, Havass J, Marki A, Falkay G. Characterization of late-pregnant rat uterine contraction via the contractility ratio in vitro significance of alpha1-adrenoceptors. Life Sci 2001; 68: 1119-29. (Pubitemid 32168038)
16. Mesiano S. Myometrial progesterone responsiveness. Semin Reprod Med 2007; 25: 5-13. (Pubitemid 46147840)
17. Russo LA, Peano BJ, Trivedi SP, Cavalcanto TD, Olenchock BA, Caruso JA, et al. Regulated expression of matrix metalloproteinases, inflammatory mediators, and endometrial matrix remodeling by 17beta-estradiol in the immature rat uterus. Reprod Biol Endocrinol 2009; 7: 124.
18. Selvais C, Gaide Chevronnay HP, Lemoine P, Dedieu S, Henriet P, Courtoy PJ, et al. Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation. Endocrinology 2009; 150: 3792-9.
19. Zhang X, Christenson LK, Nothnick WB. Regulation of MMP-9 expression and activity in the mouse uterus by estrogen. Mol Reprod Dev 2007; 74: 321-31. (Pubitemid 46147808)
20. MonckedieckV, SanneckeC, HusenB, KumbartskiM, KimmigR, TotschM, et al. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod 2009; 15: 633-43.
21. Reslan OM, Khalil RA. Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials 2012; 7: 47-70.
22. 2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol 1999; 26: 707-15. (Pubitemid 29437242)
23. Murphy JG, Khalil RA. Gender-specific reduction in contractility and [Ca(2+)](i) in vascular smooth muscle cells of female rat. Am J Physiol Cell Physiol 2000; 278: C834-44. (Pubitemid 30211314)
24. Kanashiro CA, Khalil RA. Gender-related distinctions in protein kinase C activity in rat vascular smooth muscle. Am J Physiol Cell Physiol 2001; 280: C34-45.
25. Murphy JG, Khalil RA. Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 1999; 291: 44-52. (Pubitemid 29451571)
26. 2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 1999; 19: 1034-40. (Pubitemid 29177353)
27. Wingrove CS, Garr E, Godsland IF, Stevenson JC. 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998; 1406: 169-74. (Pubitemid 28193070)
28. Schafer-Somi S, Ali Aksoy O, Patzl M, Findik M, Erunal-Maral N, Beceriklisoy HB, et al. The activity of matrix metalloproteinase-2 and -9 in serum of pregnant and non-pregnant bitches. Reprod Domest Anim 2005; 40: 46-50. (Pubitemid 40218071)
29. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMM-PRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55: 434-9.
30. Huet E, Vallee B, Szul D, Verrecchia F, Mourah S, Jester JV, et al. Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J 2008; 22: 1144-54. (Pubitemid 351519969)
31. Konttinen YT, Li TF, Mandelin J, Liljestrom M, Sorsa T, Santavirta S, et al. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium. Arthritis Rheum 2000; 43: 275-80. (Pubitemid 30395735)
32. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, et al. Amatrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000; 102: 1944-9.
33. Major TC, Liang L, Lu X, Rosebury W, Bocan TM. Extracellular matrix metallo-proteinase inducer (EMMPRIN)isinduced upon monocyte differentiation and is expressed inhuman atheroma. Arterioscler Thromb Vasc Biol 2002; 22: 1200-7. (Pubitemid 34764874)
34. Huet E, Gabison EE, Mourah S, Menashi S. Role of emmprin/CD147 in tissue remodeling. Connect Tissue Res 2008; 49: 175-9.
35. Foda HD, Rollo EE, Drews M, Conner C, Appelt K, Shalinsky DR, et al. Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, Prinomastat (AG3340). Am J Respir Cell Mol Biol 2001; 25: 717-24. (Pubitemid 33124688)
36. Mazzuca MQ, Wlodek ME, Dragomir NM, Parkington HC, Tare M. Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol 2010; 588: 1997-2010.
37. Kim CH, Lisman JE. A labile component of AMPA receptor-mediated synaptic transmission is dependent on microtubule motors, actin, and N-ethylmalei-mide- sensitive factor. J Neurosci 2001; 21: 4188-94. (Pubitemid 32538544)
38. Stennett AK, Qiao X, Falone AE, Koledova VV, Khalil RA. Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats. Am J Physiol Heart Circ Physiol 2009; 296: H745-55.
39. Webster NL, Crowe SM. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leukoc Biol 2006; 80: 1052-66. (Pubitemid 44646311)
40. Sariahmetoglu M, Crawford BD, Leon H, Sawicka J, Li L, Ballermann BJ, et al. Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation. FASEB J 2007; 21: 2486-95. (Pubitemid 47230678)
41. Wu YI, Munshi HG, SenR, Snipas SJ, Salvesen GS, FridmanR, et al. Glycosylation broadens the substrate profile of membrane type1matrix metalloproteinase. J Biol Chem 2004; 279: 8278-89. (Pubitemid 38294720)
42. Roy SC, Ghosh J. Dynamic in vivo changes in the activities of gelatinases, matrix metalloproteinases (MMPs), and tissue inhibitor of metalloproteinases (TIMPs) in buffalo (Bubalus bubalis) uterine luminal fluid during estrous cycle and early pregnancy. Mol Reprod Dev 2010; 77: 944-53.
43. Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N. Matrix metal-loproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J Obstet Gynecol Reprod Biol 2008; 139: 226-32.
44. Matsuzaki S, Maleysson E, Darcha C. Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis. Hum Reprod 2010; 25: 742-50.
45. Naruse K, Lash GE, Innes BA, Otun HA, Searle RF, Robson SC, et al. Localization of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitors for MMPs (TIMPs) in uterine natural killer cells in early human pregnancy. Hum Reprod 2009; 24: 553-61.
46. Lyons CA, Beharry KD, Nishihara KC, Akmal Y, Ren ZY, Chang E, et al. Regulation of matrix metalloproteinases (type IV collagenases) and their inhibitors in the virgin, timed pregnant, and postpartum rat uterus and cervix by prostaglandin E(2)-cyclic adenosine monophosphate. Am J Obstet Gynecol 2002; 187: 202-8. (Pubitemid 34800322)
47. LevyC, RobelP, Gautray JP, De BruxJ, Verma U, Descomps B, et al. Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. Am J Obstet Gynecol 1980; 136: 646-51. (Pubitemid 10156228)
48. MesianoS, Welsh TN. Steroid hormone controlofmyometrial contractility and parturition. Semin Cell Dev Biol 2007; 18: 321-31. (Pubitemid 47211985)
49. Perusquia M, Navarrete E. Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action. Reprod Biol Endocrinol 2005; 3: 30.
50. Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod 1998; 13: 1968-74.
51. Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril 2001; 75: 1136-40. (Pubitemid 32522610)
52. Ayoubi JM, Fanchin R, Kaddouz D, Frydman R, de Ziegler D. Uterorelaxing effects of vaginal progesterone: comparison of two methodologies for assessing uterine contraction frequency on ultrasound scans. Fertil Steril 2001; 76: 736-40. (Pubitemid 32928400)
53. He YY, Cai B, Yang YX, Liu XL, Wan XP. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci 2009; 100: 1051-61.
54. Sunday L, Osuna C, Krause DN, Duckles SP. Age alters cerebrovascular inflammation and effects of estrogen. Am J Physiol Heart Circ Physiol 2007; 292: H2333-40. (Pubitemid 47084615)
55. Edwards KM, Mills PJ. Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6. Maturitas 2008; 61: 330-3.
56. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-11. (Pubitemid 29266405)
57. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endo-thelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 1994; 93: 17-25.
58. Awad AE, Kandalam V, Chakrabarti S, Wang X, Penninger JM, Davidge ST, et al. Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. Am J Physiol Cell Physiol 2010; 298: C679-92.
59. Lekontseva O, Jiang Y, Davidge ST. Estrogen replacement increases matrix metalloproteinase contribution to vasoconstriction in a rat model of menopause. J Hypertens 2009; 27: 1602-8.
60. MishraB, KizakiK, KoshiK, UshizawaK, TakahashiT, Hosoe M, et al. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its expected roles in the bovine endometrium during gestation. Domest Anim Endocrinol 2012; 42: 63-73.
61. Mishra B, Kizaki K, Sato T, Ito A, Hashizume K. The role of extracellular matrix metalloproteinase inducer (EMMPRIN) in the regulation of bovine endometrial cell functions. Biol Reprod 2012; 87: 149.
62. Braundmeier AG, Fazleabas AT, Nowak RA. Extracellular matrix metalloproteinase inducer expression in the baboon endometrium: menstrual cycle and endometriosis. Reproduction 2010; 140: 911-20.
63. Conrad KP. Maternal vasodilation in pregnancy: the emerging role of relaxin. Am J Physiol Regul Integr Comp Physiol 2011; 301: R267-75.
64. Khalil RA, Crews JK, Novak J, Kassab S, Granger JP. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 1998; 31: 1065-9. (Pubitemid 28191498)
65. 2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol 1999; 276: R530-8. (Pubitemid 29098690)
66. Scott PA, Tremblay A, Brochu M, St-Louis J. Vasorelaxant action of 17-estradiol in rat uterine arteries: role of nitric oxide synthases and estrogen receptors. Am J Physiol Heart Circ Physiol 2007; 293: H3713-19. (Pubitemid 350230918)
67. Pepper MS. Extracellular proteolysis and angiogenesis. Thromb Haemost 2001; 86: 346-55. (Pubitemid 32663965)
68. Harris LK, Smith SD, Keogh RJ, Jones RL, Baker PN, Knofler M, et al. Trophoblast- and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling. Am J Pathol 2010; 177: 2103-15.
69. 2+ entry mechanisms of vascular contraction. J Vasc Surg 2004; 40: 1001-10. (Pubitemid 39535233)
70. Raffetto JD, Ross RL, Khalil RA. Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. J Vasc Surg 2007; 45: 373-80. (Pubitemid 46149999)
71. 2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. J Surg Res 2010; 159: 755-64.
72. Pustovrh MC, Jawerbaum A, CapobiancoE, WhiteV, Lopez-Costa JJ, Gonzalez E. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta 2005; 26: 339-48. (Pubitemid 40485871)
73. Arthur P, Taggart MJ, Zielnik B, Wong S, Mitchell BF. Relationship between gene expression and function ofuterotonic systemsin the rat during gestation, uterine activation and both term and preterm labour. J Physiol 2008; 586: 6063-76.